Michael Campa

Advisory Board Member at Grid Therapeutics - Durham, NC, US

Michael Campa's Colleagues at Grid Therapeutics
Edward Patz

Chief Executive Officer

Contact Edward Patz

Thomas Patz

Chief Operating Officer and General Counsel

Contact Thomas Patz

Scott Lyman

Chief Business Officer

Contact Scott Lyman

Michael Campa's Contact Details
HQ
919-987-7190
Location
Durham,North Carolina,United States
Company
Grid Therapeutics
Michael Campa's Company Details
Grid Therapeutics logo, Grid Therapeutics contact details

Grid Therapeutics

Durham, NC, US • 5 - 9 Employees
BioTech/Drugs

Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, North Carolina, Grid is developing the first human derived targeted immunotherapy for cancer. The antibody was discovered in exceptional outcome early stage lung cancer patients who did not progress to develop metastasis. The antibody was isolated from patient's B-cells using state of the art molecular genomic techniques. "GT103", the company's lead asset, is currently enrolling the first-in-man Phase 1 clinical trial in refractory NSCLC patients.

N/A
Details about Grid Therapeutics
Frequently Asked Questions about Michael Campa
Michael Campa currently works for Grid Therapeutics.
Michael Campa's role at Grid Therapeutics is Advisory Board Member.
Michael Campa's email address is ***@mc.duke.edu. To view Michael Campa's full email address, please signup to ConnectPlex.
Michael Campa works in the Research industry.
Michael Campa's colleagues at Grid Therapeutics are Edward Patz, Thomas Patz, Scott Lyman and others.
Michael Campa's phone number is 919-987-7190
See more information about Michael Campa